CHEK2 1100delC does not contribute to risk to breast cancer among Malay, Chinese and Indians in Malaysia

Familial Cancer

Volumn 8, Issue 4, 2009, Pages 355-358

  Thirthagiri, Eswary ^a   Cheong, Leng San ^a   Yip, Cheng Har ^b   Teo, Soo Hwang ^a  

^a CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

CHEK2 Breast cancer; Chinese; Indian; Malay

Indexed keywords

CHECKPOINT KINASE 2; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; ASIAN; BREAST CANCER; CANCER INVASION; CANCER RISK; CHINESE; COHORT ANALYSIS; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAY; MALAYSIA; MUTATIONAL ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; BREAST TUMOR; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALAYSIA; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SEQUENCE DELETION; YOUNG ADULT;

EID: 70449521317     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-009-9244-x     Document Type: Article

References (37)

1. J Bartek J Lukas 2003 Chk1 and Chk2 kinases in checkpoint control and cancer Cancer Cell 3 421 429 10.1016/S1535-6108(03)00110-7 1:CAS:528: DC%2BD3sXktlyiurg%3D 12781359 (Pubitemid 38340288)
2. H Nevanlinna J Bartek 2006 The CHEK2 gene and inherited breast cancer susceptibility Oncogene 25 5912 5919 10.1038/sj.onc.1209877 1:CAS:528: DC%2BD28XhtVSgurjP 16998506 (Pubitemid 44453447)
3. T Walsh MC King 2007 Ten genes for inherited breast cancer Cancer Cell 11 103 105 10.1016/j.ccr.2007.01.010 1:CAS:528:DC%2BD2sXitVartLw%3D 17292821 (Pubitemid 46209856)
4. T Walsh S Casadei KH Coats E Swisher SM Stray J Higgins KC Roach J Mandell MK Lee S Ciernikova L Foretova P Soucek MC King 2006 Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 1379 1388 10.1001/jama.295.12.1379 1:CAS:528: DC%2BD28Xislehurs%3D 16551709
5. C Cybulski D Wokolorczyk T Huzarski T Byrski J Gronwald B Gorski T Debniak B Masojc A Jakubowska T van de Wetering SA Narod J Lubinski 2007 A deletion in CHEK2 of 5, 395 bp predisposes to breast cancer in Poland Breast Cancer Res Treat 102 119 122 10.1007/s10549-006-9320-y 1:CAS:528: DC%2BD2sXhslCltro%3D 16897426 (Pubitemid 46294966)
6. A Shaag T Walsh P Renbaum T Kirchhoff K Nafa S Shiovitz JB Mandell P Welcsh MK Lee N Ellis K Offit E Levy-Lahad MC King 2005 Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population Hum Mol Genet 14 555 563 10.1093/hmg/ddi052 1:CAS:528:DC%2BD2MXhtV2qsL4%3D 15649950 (Pubitemid 40277471)
7. N Bogdanova N Enssen-Dubrowinskaja S Feshchenko GI Lazjuk YI Rogov O Dammann M Bremer JH Karstens C Sohn T Dork 2005 Association of two mutations in the CHEK2 gene with breast cancer Int J Cancer 116 263 266 10.1002/ijc.21022 1:CAS:528:DC%2BD2MXmtVaqt7k%3D 15810020 (Pubitemid 40967263)
8. O Kilpivaara P Vahteristo J Falck K Syrjakoski H Eerola D Easton J Bartkova J Lukas P Heikkila K Aittomaki K Holli C Blomqvist OP Kallioniemi J Bartek H Nevanlinna 2004 CHEK2 variant I157T may be associated with increased breast cancer risk Int J Cancer 111 543 547 10.1002/ijc.20299 1:CAS:528:DC%2BD2cXmsFeqtbY%3D 15239132 (Pubitemid 39045321)
9. C Cybulski B Gorski T Huzarski B Masojc M Mierzejewski T Debniak U Teodorczyk T Byrski J Gronwald J Matyjasik E Zlowocka M Lenner E Grabowska K Nej J Castaneda K Medrek A Szymanska J Szymanska G Kurzawski J Suchy O Oszurek A Witek SA Narod J Lubinski 2004 CHEK2 is a multiorgan cancer susceptibility gene Am J Hum Genet 75 1131 1135 10.1086/426403 1:CAS:528:DC%2BD2cXhtVegsrbL 15492928 (Pubitemid 39532081)
10. M Schutte S Seal R Barfoot H Meijers-Heijboer M Wasielewski DG Evans D Eccles C Meijers F Lohman J Klijn A van den Ouweland PA Futreal KL Nathanson BL Weber DF Easton MR Stratton N Rahman 2003 Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility Am J Hum Genet 72 1023 1028 10.1086/373965 1:CAS:528:DC%2BD3sXivFWgu78%3D 12610780 (Pubitemid 36403321)
11. X Dong L Wang K Taniguchi X Wang JM Cunningham SK McDonnell C Qian AF Marks SL Slager BJ Peterson DI Smith JC Cheville ML Blute SJ Jacobsen DJ Schaid DJ Tindall SN Thibodeau W Liu 2003 Mutations in CHEK2 associated with prostate cancer risk Am J Hum Genet 72 270 280 10.1086/346094 1:CAS:528: DC%2BD3sXht12rtrg%3D 12533788 (Pubitemid 36194238)
12. EH Seppala T Ikonen N Mononen V Autio A Rokman MP Matikainen TL Tammela J Schleutker 2003 CHEK2 variants associate with hereditary prostate cancer Br J Cancer 89 1966 1970 10.1038/sj.bjc.6601425 1:STN:280:DC%2BD3srjtlegsQ%3D%3D 14612911 (Pubitemid 37533278)
13. C Cybulski D Wokolorczyk T Huzarski T Byrski J Gronwald B Gorski T Debniak B Masojc A Jakubowska B Gliniewicz A Sikorski M Stawicka D Godlewski Z Kwias A Antczak K Krajka W Lauer M Sosnowski P Sikorska-Radek K Bar R Klijer R Zdrojowy B Malkiewicz A Borkowski T Borkowski M Szwiec SA Narod J Lubinski 2006 A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer J Med Genet 43 863 866 10.1136/jmg.2006.044974 1:CAS:528:DC%2BD28Xhtlelsr3I 17085682 (Pubitemid 44787112)
14. C Cybulski D Wokolorczyk J Kladny G Kurzawski J Suchy E Grabowska J Gronwald T Huzarski T Byrski B Gorski DEB T SA Narod J Lubinski 2007 Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet 15 237 241 10.1038/sj.ejhg.5201734 1:CAS:528:DC%2BD2sXmt1Oktg%3D%3D 17106448 (Pubitemid 46111863)
15. O Kilpivaara P Alhopuro P Vahteristo LA Aaltonen H Nevanlinna 2006 CHEK2 I157T associates with familial and sporadic colorectal cancer J Med Genet 43 e34 10.1136/jmg.2005.038331 1:STN:280:DC%2BD28zpsF2ltw%3D%3D 16816021
16. DW Bell JM Varley TE Szydlo DH Kang DC Wahrer KE Shannon M Lubratovich SJ Verselis KJ Isselbacher JF Fraumeni JM Birch FP Li JE Garber DA Haber 1999 Heterozygous germline hCHK2 mutations in Li-Fraumeni syndrome Science 286 2528 2531 10.1126/science.286.5449.2528 1:CAS:528:DC%2BD3cXntlGh 10617473 (Pubitemid 30026346)
17. H Meijers-Heijboer A van den Ouweland J Klijn M Wasielewski A de Snoo R Oldenburg A Hollestelle M Houben E Crepin M van Veghel-Plandsoen F Elstrodt C van Duijn C Bartels C Meijers M Schutte L McGuffog D Thompson D Easton N Sodha S Seal R Barfoot J Mangion J Chang-Claude D Eccles R Eeles DG Evans R Houlston V Murday S Narod T Peretz J Peto C Phelan HX Zhang C Szabo P Devilee D Goldgar PA Futreal KL Nathanson B Weber N Rahman MR Stratton 2002 Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 55 59 10.1038/ng879 1:CAS:528: DC%2BD38Xjt1Kns78%3D 11967536 (Pubitemid 34887638)
18. The CHEK2 Breast Cancer Case-Control Consortium 2004 CHEK2 1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies Am J Hum Genet 74 1175 1182 10.1086/421251 (Pubitemid 38669316)
19. MK Schmidt RA Tollenaar SR de Kemp A Broeks CJ Cornelisse VT Smit JL Peterse FE van Leeuwen LJ Van't Veer 2007 Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2 1100delC germline mutation J Clin Oncol 25 64 69 10.1200/JCO.2006.06.3024 1:CAS:528: DC%2BD2sXht1ejs70%3D 17132695 (Pubitemid 350003052)
20. GH de Bock M Schutte EM Krol-Warmerdam C Seynaeve J Blom CT Brekelmans H Meijers-Heijboer CJ van Asperen CJ Cornelisse P Devilee RA Tollenaar JG Klijn 2004 Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2 1100delC variant J Med Genet 41 731 735 10.1136/jmg.2004.019737 15466005 (Pubitemid 39389288)
21. H Meijers-Heijboer J Wijnen H Vasen M Wasielewski A Wagner A Hollestelle F Elstrodt R van den Bos A de Snoo GT Fat C Brekelmans S Jagmohan P Franken P Verkuijlen A van den Ouweland P Chapman C Tops G Moslein J Burn H Lynch J Klijn R Fodde M Schutte 2003 The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype Am J Hum Genet 72 1308 1314 10.1086/375121 1:CAS:528:DC%2BD3sXjslagu7s%3D 12690581 (Pubitemid 36530019)
22. P Vahteristo J Bartkova H Eerola K Syrjakoski S Ojala O Kilpivaara A Tamminen J Kononen K Aittomaki P Heikkila K Holli C Blomqvist J Bartek OP Kallioniemi HA Nevanlinna 2002 CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer Am J Hum Genet 71 432 438 10.1086/341943 1:CAS:528:DC%2BD38XlvV2qur8%3D 12094328 (Pubitemid 34800260)
23. E Kwiatkowska E Skasko A Niwinska A Wojciechowska-Lacka J Rachtan L Molong D Nowakowska B Konopka A Janiec-Jankowska Z Paszko J Steffen 2006 Low frequency of the CHEK2 1100delC mutation among breast cancer probands from three regions of Poland Neoplasma 53 305 308 1:CAS:528:DC%2BD28XosVamu7c%3D 16830057
24. MU Rashid A Jakubowska C Justenhoven V Harth B Pesch C Baisch CB Pierl T Bruning Y Ko A Benner HE Wichmann H Brauch U Hamann 2005 German populations with infrequent CHEK2 1100delC and minor associations with early-onset and familial breast cancer Eur J Cancer 41 2896 2903 10.1016/j.ejca.2005.04.049 1:CAS:528:DC%2BD2MXht1OntLzL 16239104 (Pubitemid 41713129)
25. K Offit H Pierce T Kirchhoff P Kolachana B Rapaport P Gregersen S Johnson O Yossepowitch H Huang J Satagopan M Robson L Scheuer K Nafa N Ellis 2003 Frequency of CHEK2 1100delC in New York breast cancer cases and controls BMC Med Genet 4 1 4 10.1186/1471-2350-4-1 12529183 (Pubitemid 38692968)
26. MA Caligo S Agata G Aceto R Crucianelli S Manoukian B Peissel MC Scaini E Sensi S Veschi A Cama P Radice A Viel E D'Andrea M Montagna 2004 The CHEK2 c. 1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy Hum Mutat 24 100 101 10.1002/humu.20051 1:CAS:528:DC%2BD2cXmtlShtr8%3D 15221794 (Pubitemid 38859229)
27. A Osorio R Rodriguez-Lopez O Diez M De La Hoya J Ignacio Martinez A Vega E Esteban-Cardenosa C Alonso T Caldes J Benitez 2004 The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population Int J Cancer 108 54 56 10.1002/ijc.11414 1:CAS:528:DC%2BD3sXps1entLo%3D 14618615 (Pubitemid 37444443)
28. S Zhang CM Phelan P Zhang F Rousseau P Ghadirian A Robidoux W Foulkes N Hamel D McCready M Trudeau H Lynch D Horsman ML De Matsuda Z Aziz M Gomes MM Costa A Liede A Poll P Sun SA Narod 2008 Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study Cancer Res 68 2154 2157 10.1158/0008-5472.CAN-07-5187 1:CAS:528:DC%2BD1cXktVyqurw%3D 18381420
29. DH Choi DY Cho MH Lee HS Park SH Ahn BH Son BG Haffty 2008 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation Breast Cancer Res Treat 112 569 573 10.1007/s10549-007-9878-z 1:CAS:528:DC%2BD1cXhtl2mu7bP 18175216
30. CG Song Z Hu WT Yuan GH Di ZZ Shen W Huang ZM Shao 2006 CHEK2 c. 1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23 443 445 1:CAS:528:DC%2BD2sXhtFejsr3K 16883537
31. DW Bell SH Kim AK Godwin TA Schiripo PL Harris SM Haserlat DC Wahrer CA Haiman MB Daly KB Niendorf MR Smith DC Sgroi JE Garber OI Olopade L Le Marchand BE Henderson D Altshuler DA Haber ML Freedman 2007 Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts Int J Cancer 121 2661 2667 10.1002/ijc.23026 1:CAS:528:DC%2BD2sXhtl2qsL3K 17721994 (Pubitemid 350136409)
32. AS Lee P Ang 2008 CHEK2 1100delC screening of Asian women with a family history of breast cancer is unwarranted J Clin Oncol 26 2419 10.1200/JCO.2008.16.4335 18467741 (author reply 2419-20)
33. T Rajkumar N Soumittra NK Nancy R Swaminathan V Sridevi V Shanta 2003 BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India Asian Pac J Cancer Prev 4 203 208 14507240
34. Malaysian Housing and Population Census (2000) Department of Statistics, Malaysia. http://www.statistics.gov.my
35. N Johnson O Fletcher C Naceur-Lombardelli I dos Santos Silva A Ashworth J Peto 2005 Interaction between CHEK2 1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study Lancet 366 1554 1557 10.1016/S0140-6736(05)67627-1 1:CAS:528:DC%2BD2MXhtFKhsbfJ 16257342 (Pubitemid 41540113)
36. A Broeks L de Witte A Nooijen A Huseinovic JG Klijn FE van Leeuwen NS Russell LJ van't Veer 2004 Excess risk for contralateral breast cancer in CHEK2 1100delC germline mutation carriers Breast Cancer Res Treat 83 91 93 10.1023/B:BREA.0000010697.49896.03 1:CAS:528:DC%2BD2cXnvVKq 14997059 (Pubitemid 38141897)
37. DM Friedrichsen KE Malone DR Doody JR Daling EA Ostrander 2004 Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women Breast Cancer Res 6 R629 R635 10.1186/bcr933 1:CAS:528: DC%2BD2cXpt1ajtb0%3D 15535844